Zydus MedTech partners with Braile Biomedica for TAVI device rights

Zydus MedTech, a subsidiary of Zydus Lifesciences, has entered a strategic partnership with Brazil-based Braile Biomedica to exclusively commercialize Braile's Transcatheter Aortic Valve Implantation (TAVI) technology in Europe, India, and select markets. The purchase price was not disclosed.

“Zydus MedTech, a wholly owned subsidiary of Indian pharma major Zydus Lifesciences, has obtained commercial rights to an aortic valve device from Brazil-based Braile Biomedica for Europe, India, and other select markets.”health.economictimes.indiatimes.com

• 1 source
• health.economictimes.indiatimes.comZydus MedTech bags rights of Brazilian aortic valve device, boost cardiac play, ETHealthworldOnline Bureau, ET HealthWorldApr 18, 2025

Summarized from public sources; check the original articles before acting on it.